What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Biologics

PUBLISHER: TechNavio | PRODUCT CODE: 1366478

PUBLISHER: TechNavio | PRODUCT CODE: 1366478

Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2024-2028

PUBLISHED: October 4, 2023

PAGES: 174 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The epidermal growth factor receptor (EGFR) inhibitors market is forecasted to grow by USD 6.75 bn during 2023-2028, accelerating at a CAGR of 8.6% during the forecast period. The report on the epidermal growth factor receptor (EGFR) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rise in the prevalence of major cancer indications, increasing awareness and adoption of personalized medicine, and advancements in technology and research.

Technavio's epidermal growth factor receptor (EGFR) inhibitors market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	8%
CAGR	8.6%
Incremental Value	$6.75bn

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online pharmacies

By Indication

Lung cancer
Colorectal cancer
Breast cancer
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in research areas for treatment of various types of cancer as one of the prime reasons driving the epidermal growth factor receptor (EGFR) inhibitors market growth during the next few years. Also, rise in number of drug pipelines and increasing reimbursement programs will lead to sizable demand in the market.

The report on the epidermal growth factor receptor (EGFR) inhibitors market covers the following areas:

Epidermal growth factor receptor (EGFR) inhibitors market sizing
Epidermal growth factor receptor (EGFR) inhibitors market forecast
Epidermal growth factor receptor (EGFR) inhibitors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epidermal growth factor receptor (EGFR) inhibitors market vendors that include Amgen Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Checkpoint Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Hansoh Pharmaceutical Group Co. Ltd., hutchison medipharma ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson and Johnson, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Puma Biotechnology Inc., Takeda Pharmaceutical Co. Ltd., Apollomics Inc., CULLINAN ONCOLOGY INC., and Lutris Pharma. Also, the epidermal growth factor receptor (EGFR) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72701

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global epidermal growth factor receptor (EGFR) inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global epidermal growth factor receptor (egfr) inhibitors market 2018 - 2022 ($ million)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Indication Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Indication

7.1 Market segments
Exhibit 48: Chart on Indication - Market share 2023-2028 (%)
Exhibit 49: Data Table on Indication - Market share 2023-2028 (%)
7.2 Comparison by Indication
Exhibit 50: Chart on Comparison by Indication
Exhibit 51: Data Table on Comparison by Indication
7.3 Lung cancer - Market size and forecast 2023-2028
Exhibit 52: Chart on Lung cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Lung cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Lung cancer - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Lung cancer - Year-over-year growth 2023-2028 (%)
7.4 Colorectal cancer - Market size and forecast 2023-2028
Exhibit 56: Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%)
7.5 Breast cancer - Market size and forecast 2023-2028
Exhibit 60: Chart on Breast cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Indication
Exhibit 68: Market opportunity by Indication ($ million)
Exhibit 69: Data Table on Market opportunity by Indication ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.4 Apollomics Inc.
Exhibit 122: Apollomics Inc. - Overview
Exhibit 123: Apollomics Inc. - Product / Service
Exhibit 124: Apollomics Inc. - Key news
Exhibit 125: Apollomics Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 126: AstraZeneca Plc - Overview
Exhibit 127: AstraZeneca Plc - Product / Service
Exhibit 128: AstraZeneca Plc - Key news
Exhibit 129: AstraZeneca Plc - Key offerings
12.6 Boehringer Ingelheim International GmbH
Exhibit 130: Boehringer Ingelheim International GmbH - Overview
Exhibit 131: Boehringer Ingelheim International GmbH - Business segments
Exhibit 132: Boehringer Ingelheim International GmbH - Key news
Exhibit 133: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 134: Boehringer Ingelheim International GmbH - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 135: Bristol Myers Squibb Co. - Overview
Exhibit 136: Bristol Myers Squibb Co. - Product / Service
Exhibit 137: Bristol Myers Squibb Co. - Key news
Exhibit 138: Bristol Myers Squibb Co. - Key offerings
12.8 Checkpoint Therapeutics Inc.
Exhibit 139: Checkpoint Therapeutics Inc. - Overview
Exhibit 140: Checkpoint Therapeutics Inc. - Product / Service
Exhibit 141: Checkpoint Therapeutics Inc. - Key offerings
12.9 Eli Lilly and Co.
Exhibit 142: Eli Lilly and Co. - Overview
Exhibit 143: Eli Lilly and Co. - Product / Service
Exhibit 144: Eli Lilly and Co. - Key news
Exhibit 145: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 146: F. Hoffmann La Roche Ltd. - Overview
Exhibit 147: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 148: F. Hoffmann La Roche Ltd. - Key news
Exhibit 149: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 150: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Exhibit 151: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibit 152: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibit 153: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
12.12 Johnson and Johnson
Exhibit 154: Johnson and Johnson - Overview
Exhibit 155: Johnson and Johnson - Business segments
Exhibit 156: Johnson and Johnson - Key news
Exhibit 157: Johnson and Johnson - Key offerings
Exhibit 158: Johnson and Johnson - Segment focus
12.13 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.14 Otsuka Holdings Co. Ltd.
Exhibit 163: Otsuka Holdings Co. Ltd. - Overview
Exhibit 164: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 165: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 166: Otsuka Holdings Co. Ltd. - Segment focus
12.15 Pfizer Inc.
Exhibit 167: Pfizer Inc. - Overview
Exhibit 168: Pfizer Inc. - Product / Service
Exhibit 169: Pfizer Inc. - Key news
Exhibit 170: Pfizer Inc. - Key offerings
12.16 Puma Biotechnology Inc.
Exhibit 171: Puma Biotechnology Inc. - Overview
Exhibit 172: Puma Biotechnology Inc. - Product / Service
Exhibit 173: Puma Biotechnology Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

Product Code: IRTNTR72701

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global epidermal growth factor receptor (egfr) inhibitors market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Indication - Market share 2023-2028 (%)
Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Indication
Exhibits51: Data Table on Comparison by Indication
Exhibits52: Chart on Lung cancer - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Lung cancer - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Lung cancer - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Lung cancer - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Breast cancer - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Indication ($ million)
Exhibits69: Data Table on Market opportunity by Indication ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: Apollomics Inc. - Overview
Exhibits123: Apollomics Inc. - Product / Service
Exhibits124: Apollomics Inc. - Key news
Exhibits125: Apollomics Inc. - Key offerings
Exhibits126: AstraZeneca Plc - Overview
Exhibits127: AstraZeneca Plc - Product / Service
Exhibits128: AstraZeneca Plc - Key news
Exhibits129: AstraZeneca Plc - Key offerings
Exhibits130: Boehringer Ingelheim International GmbH - Overview
Exhibits131: Boehringer Ingelheim International GmbH - Business segments
Exhibits132: Boehringer Ingelheim International GmbH - Key news
Exhibits133: Boehringer Ingelheim International GmbH - Key offerings
Exhibits134: Boehringer Ingelheim International GmbH - Segment focus
Exhibits135: Bristol Myers Squibb Co. - Overview
Exhibits136: Bristol Myers Squibb Co. - Product / Service
Exhibits137: Bristol Myers Squibb Co. - Key news
Exhibits138: Bristol Myers Squibb Co. - Key offerings
Exhibits139: Checkpoint Therapeutics Inc. - Overview
Exhibits140: Checkpoint Therapeutics Inc. - Product / Service
Exhibits141: Checkpoint Therapeutics Inc. - Key offerings
Exhibits142: Eli Lilly and Co. - Overview
Exhibits143: Eli Lilly and Co. - Product / Service
Exhibits144: Eli Lilly and Co. - Key news
Exhibits145: Eli Lilly and Co. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Overview
Exhibits147: F. Hoffmann La Roche Ltd. - Business segments
Exhibits148: F. Hoffmann La Roche Ltd. - Key news
Exhibits149: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits151: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibits152: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibits153: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
Exhibits154: Johnson and Johnson - Overview
Exhibits155: Johnson and Johnson - Business segments
Exhibits156: Johnson and Johnson - Key news
Exhibits157: Johnson and Johnson - Key offerings
Exhibits158: Johnson and Johnson - Segment focus
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Otsuka Holdings Co. Ltd. - Overview
Exhibits164: Otsuka Holdings Co. Ltd. - Business segments
Exhibits165: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits166: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits167: Pfizer Inc. - Overview
Exhibits168: Pfizer Inc. - Product / Service
Exhibits169: Pfizer Inc. - Key news
Exhibits170: Pfizer Inc. - Key offerings
Exhibits171: Puma Biotechnology Inc. - Overview
Exhibits172: Puma Biotechnology Inc. - Product / Service
Exhibits173: Puma Biotechnology Inc. - Key offerings
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits176: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits177: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations